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TITLE OF CASE Do not include “a case report” 
A sensory neuronopathy associated with cholangiocarcinoma diagnosed six years after symptom 
onset. 
 
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
 
A pure sensory neuronopathy (also referred to as a sensory ganglionopathy) is one of a handful of 
classical neurological paraneoplastic syndromes. Current guidelines recommend that in cases of 
sensory neuronopathy, a search for an underlying malignancy be pursued for up to four years. We 
report the case of a 52-year old lady with a sensory neuronopathy who was eventually diagnosed 
with a cholangiocarcinoma six years after the onset of her disease. A CT FDG-PET scan 
performed 18 and 24 months after disease onset failed to identify an underlying neoplasm. 
Immunomodulatory treatment with corticosteroids, intravenous immunogolobulins and plasma 
exchange were ineffective. Investigations for Sjogrens disease were negative. A third FDG-PET 
performed six years after symptoms onset identified a cholangiocarcinoma which was confirmed 
histologically following open resection. Since the tumour was removed our patient’s condition 
has not progressed but there has been no improvement and she remains severely disabled. 
 
BACKGROUND Why you think this case is important – why did you write it up? 
 
A pure sensory neuronopathy (also referred to as a sensory ganglionopathy) is one of a handful of 
recognised neurological paraneoplastic syndromes. Current guidelines recommend that in cases of 
sensory neuronopathy, a search for an underlying malignancy be pursued for up to four years. [1] 
In this case, a cholangiocarcinoma was detected six years after disease onset and in the absence of 
an onconeuronal antibody, one cannot be certain that this is causal of her neuropathy. Evidence of 
causality will be strengthened by the identification of additional patients with cholangiocarcnoma 
and a sensory neuronopathy. 
 
CASE PRESENTATION Presenting features, medical/social/family history 
 
A 52-year old right handed female first developed symptoms in 2009 starting with the inability to 
feel the pedals of her sewing machine.  The numbness in her feet persisted and after two years she 
developed pain and paraesthesia in the hands and progressive difficulty with her balance that 
prompted her to attend her general practitioner.  Over the following year (2012) her balance 
deteriorated rapidly such that she required the use of a wheelchair. Examination in 2012 revealed 
a tonic left pupil and severe sensory ataxia that mimicked a choreiform movement disorder and 
rendered her unable to walk. This is demonstrated in the video clip in which the patient is shown 
attempting to bring her index fingers together with her eyes closed. Limb power was normal and 
she was areflexic. There was severe impairment of all modalities of sensation. Neurophysiology 
revealed normal compound muscle action potentials and electromyography but absent sensory 
action potential in the upper and lower limbs consistent with a sensory neuronopathy.  
 
INVESTIGATIONS If relevant 
 
Initial investigations in 2012 revealed a vitamin B12 level of 168 pg/ml (108-914), however, 
despite parenteral supplementation her symptoms progressed. The patient was referred to our 
service in 2013, four years after the onset of her symptoms. A full blood screen including ANA, 
ENA, ANCA, dsDNA, vitamins B1 and B6, copper and caeruloplasmin, HIV, Hepatitis B and C 
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and serum protein electrophoresis were normal. The anti-neuronal antibody, anti CRMP5 was 
weakly positive when first tested but was subsequently negative on repeated testing. Anti-Hu 
antibodies were negative. CSF examination revealed a white cell count of 6 (normal <5), protein 
0.52 g/l, glucose 3.0 mmol/l and matched oligoclonal bands. MRI revealed flattening and signal 
change of the dorsal columns of the cervical and thoracic cords due to a loss of sensory afferent 
fibres (See figure 1). A CT of the chest, abdomen and pelvis and FDG-CT PET at the time of 
referral and after 6 months were both normal (see figure 1). A sural nerve biopsy revealed a 
severe chronic axonal neuropathy with minimal epineurial inflammation. Schirmer’s test was 
positive but a labial minor salivary gland biopsy, to investigate the possibility of Sjogrens disease, 




DIFFERENTIAL DIAGNOSIS If relevant 
 
Peripheral neuropathies that solely affect the sensory nerves are termed pure sensory 
neuropathies, sensory neuronopathies or dorsal root ganglionopathies. Paraneoplasia accounts for 
approximately 20% of cases of sensory neuronopathy with the remainder being either idiopathic, 
toxic (cisplatin or excess pyridoxine) or mitochondrial (Sensory Ataxic Neuropathy Dysarthria 
and Ophthalmoplegia Syndrome). [2] 
 
 
TREATMENT If relevant  
 
A diagnosis of an acquired sensory neuronopathy was made and the patient was treated for a 
possible inflammatory aetiology based on our previous experience with three courses of 
intravenous immunoglobulin with no response. [3] Corticosteroids were briefly tried but were not 
tolerated. Two courses of plasma exchange were ineffective.  
 
 
OUTCOME AND FOLLOW-UP   
 
Six years after the onset of symptoms the patient underwent a 3rd FDG-PET and CT scan which 
revealed both FDG avid uptake and thickening of the gallbladder fundus (see figure 1). A 
laparoscopic examination revealed cancer of the gallbladder and the patient underwent an open 
cholecystectomy, gallbladder fossa resection, lymphadenectomy and port excision. Histology 
revealed a poorly differentiated cholangiocarcinoma. Since the tumour was removed our patient’s 
condition has not progressed but there has been no improvement and our patient remains severely 
disabled. On the basis of published guidelines on paraneoplastic neurological syndromes [4], as 
the cholangiocarcinoma was not detected within 5 years of symptom onset and in the absence of 
an onco-neuronal antibody, one cannot be certain that the cholangiocarcinoma was causal of the 
sensory neuronopathy. 
 
DISCUSSION Include a very brief review of similar published cases  
 
The non-length dependent nature of the sensory loss (involvement of the face, lips and trunk), 
areflexia, and predominantly large fibre sensory loss suggest the presence of a sensory 
neuronopathy as opposed to a sensory neuropathy. As is typical for patients with a sensory 
neuronopathy, despite severe disability, power is preserved. Paraneoplastic sensory 
neuronopathies are most frequently associated with small cell lung and breast cancer. [1] 
Cholangiocarcinoma is a recognised cause of paraneoplastic hypercalcaemia, necrotic migratory 
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erythema and alopecia but is rarely associated with paraneoplastic neurological disease. [5-7] Due 
to the significant time interval between symptom onset and detection of the cholangiocarcinoma 
and the absence of an onconeuronal antibody, one cannot be certain that our patient has a 
paraneoplastic as opposed to an idiopathic sensory neuronopathy. This case raises the important 
question of how long such patients should be investigated for an underlying tumour after disease 
onset.  This case also illustrates the difficulty in proving causality of a tumour detected after 
several years.  As sensory neurons are unable to regenerate following presumed apoptotic cell 
death, removal of a causal tumour is unlikely to lead to a clinical improvement but may halt 
progression. 
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
 
1. A thorough search for an underlying tumour should be performed in patients presenting 
with a sensory neuronopathy 
 
2. A search for an underlying tumour in potentially paraneoplastic disease should continue 
for several years unless an alternative cause for the neuropathy is identified  
 
 
3. In the absence of onconeural antibodies the discovery of a tumour after five years of 
follow-up may not definitely demonstrate that the neurological syndrome is paraneoplastic 
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FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
 
Figure 1. This figure shows a T2 weighted MRI of the cervical (A) and thoracic (B) cords 
demonstrating flattening and signal change of the dorsal columns due to a loss of sensory afferent 
fibres (highlighted by the red arrows). C shows a normal FDG-CT PET at the time of referral. D 
and E show images from a 3rd FDG-PET and CT scan performed six years after symptom onset 
demonstrating FDG avid uptake and thickening of the gallbladder fundus (highlighted by the red 
arrows). 
 
Video. This video shows the patient attempting to bring the index fingers of her outstretched 
arms together, initially with her eyes open and subsequently with her eyes closed. As a result of 
loss of proprioception the patient is unaware of the position of her limbs with the eyes closed and 
is unable to bring her index fingers together. Abnormal movements in sensory neuronopathies are 
typically athetoid.  The striking asymmetry in the movements correlates with more severe sensory 
loss on the left side on examination. Pseudoathetoid movements were present in the feet. 
 
PATIENT’S PERSPECTIVE Optional but strongly encouraged – this has to be written 
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